Cart
sales@molnova.com
Ralitoline
CAS No. 1089085-40-4
Ralitoline( —— )
Catalog No. M34390 CAS No. 1089085-40-4
Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 182 | In Stock |
|
| 10MG | 274 | In Stock |
|
| 25MG | 448 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRalitoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionRalitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
-
DescriptionRalitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1089085-40-4
-
Formula Weight296.77
-
Molecular FormulaC13H13ClN2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(NC1=C(C)C=CC=C1Cl)=O)=C2N(C)C(=O)CS2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Nefopam hydrochlorid...
Nefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.
-
LTGO-33
LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.
-
PF-04531083
PF-04531083 (PF 4531083) is a potent and selective, orally available sodium channel Nav1.8 blocker for treatment of pain.
